Table 4 Laboratory results of investigations of pregnant and non-pregnant women with confirmed SARS-CoV-2 infection
From: Covid-19 infection in pregnant women in Dubai: a case-control study
Pregnant | Non-pregnant | ||||||
|---|---|---|---|---|---|---|---|
Number tested/Total [≥ or ≤ cut-off value] (%) | Number tested/Total [≥ or ≤ cut-off value] (%) | ||||||
Reference range** | On admission | Peak | On discharge | Reference range** | On admission | Peak | On discharge |
Hb (< 11 g/dl) | 48/75 (64) | 14/43 (33) | 22/46 (48) | Hb (<12 g/dl) | 57/84 (68) | 11/23 (48) | 13/24 (54) |
WBC (> 16 x10^3/uL) | 3/74 (4) | 5/45 (11) | 0/46 (28) | WBC (>11 x 10^3/uL) | 1/84 (1) | 2/23 (9) | 1/24 (4) |
Lymphocyte (<1.0 x 10^3/uL) | 15/75 (20) | 14/38 (37) | 4/41 (10) | Lymphocyte (<0.8 x 10^3/uL) | 12/81 (15) | 6/18 (33) | 3/18 (17) |
PLT (<150 x 10^3/uL) | 9/75 (12) | 8/44 (18) | 8/47 (17) | PLT (<150 x 10^3/uL) | 4/83 (5) | 2/23 (9) | 4/24 (17) |
PLT (>400 x 10^3/uL) | 2/75 (3) | 1/75 (2) | 0/47 (0) | PLT (>400 x 10^3/uL) | 1/83 (1) | 1/23 (4) | 0/24 (0) |
CRP (>7 mg/L) | 28/73 (38) ** | 15/22 (68) | 14/34 (41) | CRP (>7 mg/L) | 13/78 (16) | 8/16 (50) | 4/24 (17) |
PT (>14 seconds) | 4/45 (9) | 2/19 (11) | 0/14 (0) | PT (>14 seconds) | 4/72 (6) | 1/7 (14.3) | 0/7 (0) |
PTT (>38 seconds) | 17/51 (33) ** | 9/16 (56) | 6/13 (46) | PTT (>38 seconds) | 42/72 (58) | 6/7 (86) | 5/7 (71) |
Bilirubin (>1.2 mg/dL) | 2/65 (3) | 3 (14) | 3/21 (14) | Bilirubin (>1.2 mg/dL) | 1/80 (1) | 0/14 (0) | 1/16 (6) |
SGPT (>40 iu/ L) | 5/65 (8) | 11/25 (44) | 7/28 (25) | SGPT (>40 iu/ L) | 4/81 (5) | 7/16 (44) | 5/17 (29) |
SGOT (>40 iu/ L) | 4/44 (9)) | 516 (31) | 4/16 (25) | SGOT (>40 iu/ L) | 1/32 (3) | 3/4 (75) | 1/5 (20) |
LDH (>524 U/L) | 13/70 (19) | 16/30 (53) | 10/29 (35) | LDH (>222 U/L) | 8/72 (11) | 8/16 (50) | 1/13 (8) |
PCT, (>0.05 ng/ml) | 30/64 (47) * | 20/24 (83) | 14/23 (61) | PCT, (>0.05 ng/ml) | 19/69 (28) | 7/12 (58) | 6/13 (46) |
Ferritin (>116 ng/ml) | 4/69 (6) | 8/31 (26) | 6/32 (19) | Ferritin (>150 ng/ml) | 4/64 (6) | 2/12 (17) | 3/13 (8) |
D-Dimer (>0.5 mcg/ml FEU) | 32/63 (51) ** | 15/26 (58) | 9/29 (31) | D-Dimer (>0.5 mcg/ml FEU) | 3/50 (6) | 3/11 (27) | 1/10 (10) |